DK1379650T3 - Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse heraf - Google Patents

Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse heraf

Info

Publication number
DK1379650T3
DK1379650T3 DK01988772T DK01988772T DK1379650T3 DK 1379650 T3 DK1379650 T3 DK 1379650T3 DK 01988772 T DK01988772 T DK 01988772T DK 01988772 T DK01988772 T DK 01988772T DK 1379650 T3 DK1379650 T3 DK 1379650T3
Authority
DK
Denmark
Prior art keywords
methods
preferred
preferred segments
neural protein
sequences
Prior art date
Application number
DK01988772T
Other languages
Danish (da)
English (en)
Inventor
Judith Fitzpatrick
Paul Averback
Ma Soledad S Focht
Riza Bibiano
Original Assignee
Nymox Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nymox Pharmaceutical Corp filed Critical Nymox Pharmaceutical Corp
Application granted granted Critical
Publication of DK1379650T3 publication Critical patent/DK1379650T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01988772T 2000-10-27 2001-10-25 Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse heraf DK1379650T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/697,590 US7259232B1 (en) 2000-10-27 2000-10-27 Preferred segments of neural thread protein

Publications (1)

Publication Number Publication Date
DK1379650T3 true DK1379650T3 (da) 2006-10-23

Family

ID=24801714

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01988772T DK1379650T3 (da) 2000-10-27 2001-10-25 Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse heraf

Country Status (15)

Country Link
US (2) US7259232B1 (fr)
EP (2) EP1379650B1 (fr)
JP (1) JP2005512500A (fr)
KR (1) KR100843792B1 (fr)
CN (1) CN1492926A (fr)
AT (1) ATE330011T1 (fr)
AU (1) AU2002232392A1 (fr)
BR (1) BR0114977A (fr)
CA (1) CA2427070A1 (fr)
CY (1) CY1105380T1 (fr)
DE (1) DE60120782T2 (fr)
DK (1) DK1379650T3 (fr)
ES (1) ES2266296T3 (fr)
PT (1) PT1379650E (fr)
WO (1) WO2002034915A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002302239B2 (en) * 2000-10-27 2006-12-14 Nymox Corporation Method of preventing cell death using segments of neural thread proteins
EP1541166B1 (fr) * 2001-05-16 2007-12-19 Nymox Corporation Prevention de la mort cellulaire a l'aide de segments de NTP
JP2004529179A (ja) 2001-05-16 2004-09-24 ナイモックス コーポレーション 神経線維タンパク質のセグメントを使用する細胞死の予防法
BR0209990A (pt) * 2001-05-25 2004-06-29 Nymox Corp Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
US7544771B2 (en) * 2005-02-23 2009-06-09 Nymox Corporation Protein and its use in diagnosing Alzheimer's disease
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068375A3 (fr) 1981-06-22 1983-04-13 G.D. Searle & Co. Techniques d'ADN recombinant pour la production de relaxine
SE8300693L (sv) 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5084559A (en) 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
EP0378924B1 (fr) 1988-12-21 1996-11-13 The General Hospital Corporation Détection de maladies ou dysfonctions neurologiques
US5948634A (en) 1988-12-21 1999-09-07 The General Hospital Coporation Neural thread protein gene expression and detection of alzheimer's disease
EP0671470B9 (fr) * 1994-03-07 2004-11-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Enzyme libérant du tréhalose, ADN codant pour cela, leur préparation et utilisation
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
US5958416A (en) 1994-12-16 1999-09-28 Regents Of The University Of Minnesota Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
US6610506B1 (en) * 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
US6013763A (en) 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
EP1030819A4 (fr) 1997-09-30 2001-11-21 Cel Sci Corp Polypeptide immunogenique conjugue destine au traitement du virus herpes simplex
WO2000001720A2 (fr) 1998-07-02 2000-01-13 President And Fellows Of Harvard College Compositions et procedes de traitement de cellules infectees par un papillomavirus
AU3517000A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. 50 human secreted proteins
JP2002539842A (ja) 1999-03-26 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４５個のヒト分泌タンパク質
JP2004529179A (ja) 2001-05-16 2004-09-24 ナイモックス コーポレーション 神経線維タンパク質のセグメントを使用する細胞死の予防法

Also Published As

Publication number Publication date
AU2002232392A1 (en) 2002-05-06
ATE330011T1 (de) 2006-07-15
CA2427070A1 (fr) 2002-05-02
US7259232B1 (en) 2007-08-21
EP1379650A2 (fr) 2004-01-14
CY1105380T1 (el) 2010-04-28
EP1702985A2 (fr) 2006-09-20
ES2266296T3 (es) 2007-03-01
EP1702985A3 (fr) 2007-03-07
BR0114977A (pt) 2006-05-09
US20090258426A1 (en) 2009-10-15
WO2002034915A2 (fr) 2002-05-02
DE60120782D1 (de) 2006-07-27
EP1379650B1 (fr) 2006-06-14
WO2002034915A3 (fr) 2003-11-20
KR20030067681A (ko) 2003-08-14
KR100843792B1 (ko) 2008-07-03
JP2005512500A (ja) 2005-05-12
CN1492926A (zh) 2004-04-28
PT1379650E (pt) 2006-10-31
DE60120782T2 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
ID28299A (id) Protein-protein reseptor seperti toll manusia metoda-metoda dan reagen-reagen yang berhubungan
EA199900355A1 (ru) Теломераза обратная тринскриптаза
SE0103754L (sv) Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
NO20001599L (no) Apolipoprotein A-1 agonister og deres anvendelse for Õ behandle dyslipidemiske forstyrrelser
DK0552240T3 (da) Ny metode til behandling af depression
DE60120782D1 (de) Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DK0815231T3 (da) Anvendelse af neuronalt apoptosisinhibitorprotein (NAIP)
DK0845034T3 (da) Peptid med pronociceptive egenskaber
DE19881185D2 (de) Vorrichtung zur Zerstörung bzw. Zertrümmerung von Konkrementen
DK1133997T3 (da) Beta-interferon til behandling af immunsygdomme
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
WO2002000719A3 (fr) Nouveaux recepteurs
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
DE60139458D1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
BR9914090A (pt) ácidos nucléicos codificando uma sub-unidade gama da proteìna g envolvida em transdução sensorial
DK0779297T3 (da) Antigene peptider med glycinsubstitutioner
ATE414154T1 (de) Moraxella (branhamella) catarrhalis antigene
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
NO20023899D0 (no) Peptid og nukleinsyre som koder for dette for påvisning, diagnose og terapi av sykdommer i nervesystemet
WO2002016435A3 (fr) Proteines humaines 7tm et polynucleotides codant ces proteines
DE60142047D1 (de) Ein humanes homolog des db4/ask1 proteins, nukleinsäuren und methoden diesbezüglich